Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.

Vitamin D is a steroid hormone that regulates calcium homeostasis and bone metabolism. The active form of vitamin D [1 alpha,25-dihydroxyvitamin D(3) (1,25D3)] acts through both genomic and nongenomic pathways. 1,25D3 has antitumor effects in a variety of cancers, including colorectal, prostate, breast, ovarian, and skin cancers. 1,25D3 exerts growth-inhibitory effects in cancer cells through the induction of apoptosis, cell cycle arrest, and differentiation. The mechanisms regulating 1,25D3-induced apoptosis remain unclear. We investigated the role of nongenomic signaling in 1,25D3-mediated apoptosis in squamous cell carcinoma (SCC) cells. 1,25D3 induced rapid and sustained activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) 1/2 pathways in SCC cells. These effects were nongenomic: they occurred rapidly and were not inhibited by cycloheximide or actinomycin D. To examine whether the nongenomic activation of Akt and ERK1/2 plays a role in 1,25D3-mediated apoptosis, the expression of Akt or ERK1/2 was reduced by small interfering RNA (siRNA). siRNA-Akt significantly enhanced 1,25D3-induced apoptosis as indicated by increased levels of Annexin V-positive cells and increased sub-G(1) population and DNA fragmentation. In contrast, siRNA-ERK1/2 had no effects on 1,25D3-induced apoptosis. In addition, siRNA-Akt transfection followed by 1,25D3 treatment induced apoptosis much sooner than 1,25D3 alone. siRNA-Akt and 1,25D3 induced caspase-10 activation, suppressed the expression of c-IAP1 and XIAP, and promoted 1,25D3-induced caspase-3 activation. These results support a link between 1,25D3-induced nongenomic signaling and apoptosis. 1,25D3 induces the activation of phosphatidylinositol 3-kinase/Akt, which suppresses 1,25D3-mediated apoptosis and prolongs the survival of SCC cells.

[1]  A. Dusso,et al.  Vitamin D , 2022, Reactions Weekly.

[2]  F. Pattou,et al.  1,25-dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the fas receptor , 2006, Apoptosis.

[3]  T. Wheeler,et al.  The emerging role of the PI3-K-Akt pathway in prostate cancer progression , 2005, Prostate Cancer and Prostatic Diseases.

[4]  M. Almeida,et al.  Nongenotropic, Anti-Apoptotic Signaling of 1α,25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes , 2005, Journal of Biological Chemistry.

[5]  S. Bao,et al.  The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.

[6]  S. Nicosia,et al.  Induction of Ovarian Cancer Cell Apoptosis by 1,25-Dihydroxyvitamin D3 through the Down-regulation of Telomerase* , 2004, Journal of Biological Chemistry.

[7]  P. Hu,et al.  Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death* , 2004, Journal of Biological Chemistry.

[8]  A. Norman,et al.  The Vitamin D Receptor Is Present in Caveolae-Enriched Plasma Membranes and Binds 1α,25(OH)2-Vitamin D3 in Vivo and in Vitro , 2004 .

[9]  J. Henderson,et al.  Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways. , 2004, Bone.

[10]  B. Boyan,et al.  Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Hershberger,et al.  Anti-tumor activity of calcitriol: pre-clinical and clinical studies , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  M. Farach-Carson,et al.  Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS) binding protein , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  S. Nicosia,et al.  Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)* , 2004, Journal of Biological Chemistry.

[14]  A. Norman,et al.  Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Degreef,et al.  1,25‐dihydroxyvitamin D3 inhibits ultraviolet B‐induced apoptosis, Jun kinase activation, and interleukin‐6 production in primary human keratinocytes , 2003, Journal of cellular biochemistry.

[16]  P. N. MacDonald,et al.  Vitamin D: more than a "bone-a-fide" hormone. , 2003, Molecular endocrinology.

[17]  D. Conrad,et al.  The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. , 2003, Cancer research.

[18]  C. Fegan,et al.  The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. , 2003, Blood.

[19]  F. Pattou,et al.  1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20. , 2002, Endocrinology.

[20]  Anthony W. Norman,et al.  Calcium and Calpain as Key Mediators of Apoptosis-like Death Induced by Vitamin D Compounds in Breast Cancer Cells* , 2002, The Journal of Biological Chemistry.

[21]  J. Liao,et al.  1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. , 2002, Circulation research.

[22]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[23]  R. Balling,et al.  Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. , 2002, Molecular endocrinology.

[24]  B. Boyan,et al.  1α,25-Dihydroxyvitamin D3 and 24R,25-Dihydroxyvitamin D3 Modulate Growth Plate Chondrocyte Physiology via Protein Kinase C-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase. , 2002, Endocrinology.

[25]  C. Buitrago,et al.  Nongenomic action of 1α,25(OH)2‐vitamin D3 , 2002 .

[26]  P. Hershberger,et al.  Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[28]  H. Perlman,et al.  Constitutively Activated Akt-1 Is Vital for the Survival of Human Monocyte-Differentiated Macrophages , 2001, The Journal of experimental medicine.

[29]  T. Mcguire,et al.  Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. , 2001, The Journal of biological chemistry.

[30]  P. Hershberger,et al.  Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  J. Welsh,et al.  Role of Mitochondria and Caspases in Vitamin D-mediated Apoptosis of MCF-7 Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[32]  C. Duckett,et al.  c-IAP1 Is Cleaved by Caspases to Produce a Proapoptotic C-terminal Fragment* , 2001, The Journal of Biological Chemistry.

[33]  C. Paraskeva,et al.  Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.

[34]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[35]  T. Soderling.  The Ca-calmodulin-dependent protein kinase cascade. , 1999, Trends in biochemical sciences.

[36]  P. Hershberger,et al.  1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. , 1999, Cancer research.

[37]  T. Giordano,et al.  1α,25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death. , 1999, Endocrinology.

[38]  P. Baumann,et al.  DNA end-joining catalyzed by human cell-free extracts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Perlman,et al.  Bax‐mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity , 1998, The EMBO journal.

[40]  Wei-dong Yu,et al.  Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. , 1997, Cancer research.

[41]  M. C. McElwain,et al.  Vitamin D: an antiproliferative agent with potential for therapy of squamous cell carcinoma. , 1997, American journal of otolaryngology.

[42]  M. Wehling.  Nongenomic actions of steroid hormones , 1994, Trends in Endocrinology & Metabolism.

[43]  H. Perlman,et al.  TNF-alpha-induced apoptosis of macrophages following inhibition of NF-kappa B: a central role for disruption of mitochondria. , 2004, Journal of immunology.

[44]  A. Norman,et al.  The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. , 2004, Molecular endocrinology.

[45]  Anthony W. Norman,et al.  Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model , 2004, Nature Reviews Drug Discovery.

[46]  John Calvin Reed,et al.  Apoptosis Induction by 1,25-Dihydroxyvitamin D 3 in Prostate Cancer 1 , 2002 .

[47]  T. Giordano,et al.  1 a , 25-Dihydroxyvitamin D 3 UpRegulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell , 1999 .